English to Arabic Medical Medical: Pharmaceuticals Clinical Study

The present international, multi-center, open-label, single-arm study constitutes an expanded access program (EAP) to make everolimus available in emergent growth markets (EGM) countries until it is approved or reimbursed, for the treatment of post-menopausal women with estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative "locally advanced" or metastatic breast cancer